Amgen and Hoffmann-La Roche extend European collaboration.THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif.--(BUSINESS WIRE)--April 14, 1997--Amgen (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMGN) Monday announced that it has entered into an agreement with F. Hoffmann-La Roche Ltd. under which Amgen and Roche (AMRO AMRO Regional Office for the Americas (WHO, Washington DC) AMRO American Robin (species) AMRO Amsterdam-Rotterdam Bank (now ABN AMRO) AMRO Association Maladie de Rendu-Osler ) will collaborate on the development of a second generation G-CSF G-CSF granulocyte colony-stimulating factor. G-CSF granulocyte-colony stimulating factor. G-CSF Granulocyte colony-stimulating factor Molecular therapeutics A biological response modifier, the recombinant DNA form of product for the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community and Roche will grant to Amgen rights to certain intellectual property in the United States and other geographic markets. In connection with this expansion of AMRO, Roche's participation with Amgen in the sales of NEUPOGEN (R) in the European Union will be extended to the year 2010. Prior to this extension, Roche's participation in AMRO was scheduled to phase out over the next several years. The extension will not affect the planned transition from Roche to Amgen of responsibility for marketing, distribution and other key functions of AMRO. F. Hoffmann-La Roche Ltd., headquartered in Basel, Switzerland, is a world leader in research-based health care with principal businesses in pharmaceuticals, diagnostics, vitamins, and fragrances and flavors. Roche discovers, develops and markets prescription drugs in key therapeutic areas such as virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression , infectious diseases, cardiology, oncology, transplantation and obesity. Amgen is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller . -0- Note to Editors: An electronic version of this news release may be accessed via Amgen's web site at www.Amgen.com . Visit the Corporate Center and click on Amgen News. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Amgen News section of the web site. CONTACT: Amgen, Thousand Oaks Andrea Rothschild, 805/447-6287 (media) Denise Powell, 805/447-4346 (investors) or F. Hoffmann-La Roche Ltd., Basel Roland Haefeli, 011-41-61-687-91-79 (media) Rudolf Weigold, 011-41-61-688-48-66 (investors) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion